Stock Market Review 29AUG #shorts

Pfizer expects fewer people needed for Lyme disease vaccine trial

Pfizer said it expects fewer people will be needed to complete its Phase III trial of Valneva’s Lyme disease vaccine candidate than originally thought. The

August 24, 2023

Researchers receive CAD 45 million to study new psychosis treatments

One out of 100 people will experience a psychotic episode in their lifetime, and these usually appear in late adolescence or early adulthood.

November 6, 2024

Results from a nested randomized controlled trial for BCG vaccination against recurrent herpes labialis

Researchers examined the effect of Bacillus Calmette-Guérin (BCG) vaccination on attenuating herpes labialis (cold sore) recurrences.

September 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.